Philip Morris International: Market Is Underestimating The Company's True Growth Prospects
Philip Morris' impressive Q3 results highlight robust performance in both core and reduced-risk products. Read why I remain ...
nation20 小时Opinion
Balancing between harm reduction and prohibition of nicotine pouches
The recent decision by the US Food and Drug Administration (FDA) to authorise the marketing of 20 ZYN nicotine pouches has ...